These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4402698)

  • 1. Clinical, electrocardiographic, and haemodynamic effects of digitalis (ouabain) in angina pectoris.
    Sharma B; Majid PA; Meeran MK; Whitaker W; Taylor SH
    Br Heart J; 1972 Jun; 34(6):631-7. PubMed ID: 4402698
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of alprenolol on hemodynamics in angina pectoris.
    Cullhed I
    Acta Med Scand; 1973 May; 193(5):411-8. PubMed ID: 4717322
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on digitalis. XVII. Effects of ouabain on the hemodynamic response to exercise in patients with mitral stenosis in normal sinus rhythm.
    Beiser GD; Epstein SE; Stampfer M; Robinson B; Braunwald E
    N Engl J Med; 1968 Jan; 278(3):131-7. PubMed ID: 5634967
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic factors associated with the production of pain in angina pectoris.
    Sharma B; Majid PA; Taylor SH
    Eur J Cardiol; 1978 Jan; 6(5):367-82. PubMed ID: 624318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the symptomatic, electrocardiographic and haemodynamic effects of acute and long term -blockade in angina pectoris.
    Sharma B; Taylor SH
    Br J Pharmacol; 1971 Oct; 43(2):470P-471P. PubMed ID: 4400578
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical management of patients with angina pectoris.
    Goldstein RE; Epstein SE
    Prog Cardiovasc Dis; 1972 Jan; 14(4):360-98. PubMed ID: 4400516
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
    Aström H; Vallin H
    Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of beta-adrenergic blockade (propranolol) on left ventricular hemodynamics and the electrocardiogram during exercise-induced angina pectoris.
    Dwyer EM; Wiener L; Cox JW
    Circulation; 1968 Aug; 38(2):250-60. PubMed ID: 5666841
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic effects of different beta blockers in angina pectoris.
    Aström H; Jonsson B
    Scott Med J; 1977 Jan; 22(1):64-8. PubMed ID: 13496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cedilanid-D and alprenolol in angina pectoris.
    Ekelund LG; Johnsson G; Melcher A; Orö L
    Eur J Clin Pharmacol; 1973 Aug; 6(2):113-8. PubMed ID: 4769694
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic effects of beta-receptor blocking agents and digitalis in ischaemic coronary heart disease with angina pectoris.
    Dunér H; Pernow B
    Acta Med Scand; 1973 Dec; 194(6):517-23. PubMed ID: 4589794
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemodynamic and electrocardiographic effects of practolol during upright exercise in coronary heart disease.
    Rousseau MF; Brasseur LA; Detry JM
    Cardiovasc Res; 1973 May; 7(3):306-12. PubMed ID: 4146653
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemodynamic effects of beta-adrenergic blockade.
    Aström H
    Br Heart J; 1968 Jan; 30(1):44-9. PubMed ID: 5637556
    [No Abstract]   [Full Text] [Related]  

  • 15. Divergent effects of diltiazem in patients with exertional angina.
    Hossack KF; Bruce RA; Ritterman JB; Kusumi F; Trimble S
    Am J Cardiol; 1982 Feb; 49(3):538-46. PubMed ID: 7058765
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic effects of angina pectoris, and of nitroglycerin in normal and anginal subjects.
    Hoeschen RJ; Bousvaros GA; Klassen GA; Fam WM; McGregor M
    Br Heart J; 1966 Mar; 28(2):221-30. PubMed ID: 5006472
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta adrenergic blocking drugs. Present position and future development.
    Fitzgerald JD
    Acta Cardiol; 1972; ():Suppl 15:199-2. PubMed ID: 4147608
    [No Abstract]   [Full Text] [Related]  

  • 19. Perhexilene maleate in treatment of angina pectoris.
    Lyon LJ; Nevins MA; Risch S; Henry S
    Lancet; 1971 Jun; 1(7712):1272-4. PubMed ID: 4104721
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris.
    Majid PA; Schreuder JE; de Feyter PJ; Roos JP
    J Cardiovasc Pharmacol; 1980; 2(4):435-44. PubMed ID: 6156341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.